Farther Finance Advisors, LLC Dia Medica Therapeutics Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 4,235 shares of DMAC stock, worth $25,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,235Holding current value
$25,240% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DMAC
# of Institutions
84Shares Held
8.12MCall Options Held
19.6KPut Options Held
16.5K-
Israel Englander Millennium Management LLC | New York, Ny1.19MShares$7.08 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX875KShares$5.22 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA723KShares$4.31 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$4.24 Million0.0% of portfolio
-
Morgan Stanley New York, NY580KShares$3.45 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $158M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...